Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LRRC8E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TBX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRTAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF517 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
R3HDML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TINCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDRT15L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSD17B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF197 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR2C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYSLTR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927069 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on